The US Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic (semaglutide) to reduce certain risks associated...
Following Eli Lilly's disappointing earnings showing last week, Novo Nordisk’s latest report on the performance of its GLP-1 sta...
Allurion Technologies has presented data from two studies showing the efficacy of its swallowable gastric balloon in causing signi...